SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-22-005284
Filing Date
2022-02-14
Accepted
2022-02-14 16:10:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10033932_sc13ga.htm SC 13G/A 65809
  Complete submission text file 0001140361-22-005284.txt   67312
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Subject) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79996 | Film No.: 22631801
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address
Sooch Mina (Filed by) CIK: 0001674006 (see all company filings)

Type: SC 13G/A